Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors

SIMPLE SUMMARY: Although immune checkpoint inhibitors improve the survival of patients with advanced gastrointestinal cancers, they also cause a series of immune-related adverse events, which could sometimes be lethal and may hamper the effectiveness of anticancer therapies. The purpose of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhening, Xie, Tong, Qi, Changsong, Zhang, Xiaotian, Shen, Lin, Peng, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367581/
https://www.ncbi.nlm.nih.gov/pubmed/35954401
http://dx.doi.org/10.3390/cancers14153736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367581/
https://www.ncbi.nlm.nih.gov/pubmed/35954401
http://dx.doi.org/10.3390/cancers14153736

Ejemplares similares